BACKGROUND:Pharmacological postconditioning (PostC) is an emerging and safer cardioprotective strategy against myocardial ischemia-reperfusion injury (MIRI), involving the administration of therapeutic agents at the onset of reperfusion. Activation of the cannabinoid B2 receptor plays a crucial role in cardioprotection across various cardiovascular pathologies. AM-1241, a selective cannabinoid B2 receptor agonist, exhibits multiple pharmacological properties, including anti-oxidant, anti-inflammatory, anti-apoptotic, and cardioprotective effects.
METHODOLOGY:MIRI was induced in isolated Wistar rat hearts using the Langendorff Power Lab system by subjecting them to 30 min of global ischemia followed by 120 min of reperfusion. AM-1241 PostC (3 μM and 6 μM) was given through four cycles of 30-s ischemia and reperfusion (stoppage/free flow of the drug, respectively) before the prolonged 120-min reperfusion.
RESULTS:MIRI-induced myocardial damage was evident through increased infarct size, elevated cardiac injury markers such as Lactate dehydrogenase-1 (LDH-1), Creatine kinase-MB (CK-MB), Cardiac troponin-I (C-tPn-I), impaired hemodynamic parameters including heart rate (HR), coronary flow rate (CFR), left ventricular developed pressure (LVDP), rate pressure product (RPP), +dp/dtmax, -dp/dtmin, and biochemical alterations such as increased thiobarbituric acid reactive species (TBARS), tumor necrosis factor-α (TNF-α), transforming growth factor- β (TGF-β), Bax, caspase-3; decreased glutathione reductase (GSH) and catalase. AM-1241 PostC significantly reduced infarct size and cardiac injury markers while improving hemodynamic and biochemical parameters. However, prior PostC of AM-630 (selective cannabinoid B2 receptor antagonist; 25 μM and 50 μM) and BML-275, an AMP activated protein kinase (AMPK) mediated autophagy inhibitor; 10 μM and 20 μM substantially abolished the cardioprotective effects of AM-1241 PostC.
CONCLUSION:These findings suggest that AM-1241 PostC exerts cardioprotective effects in MIRI through modulation of inflammatory, fibrosis, apoptotic and AMPK-mediated autophagy pathways.